Rapid detection of β-thalassemia alleles in egypt using naturally or amplified created restriction sites and direct sequencing:: A step in disease control

被引:25
作者
Hussein, Gehan
Fawzy, Manal
El Serafi, Taher
Ismail, Emad F.
El Metwally, Dina
Saber, Mohamed A.
Giansily, Muriel
Schved, Jean-Francois
Pissard, Serge
Martinez, Patricia Aguilar
机构
[1] Laboratory of Hematology, Saint Eloi Hospital, CHU of Montpellier, Montpellier
[2] Department of Biochemistry, Faculty of Medicine, Suez Canal University, Ismailia
[3] Department of Pediatrics, Faculty of Medicine, Suez Canal University, Ismailia
[4] Department of Biochemistry, Tudor Belhars Research Institute, Cairo
[5] INSERM U654, Laboratory of Biochemistry and Molecular Genetics, Henri Mondor Hospital, Créteil
[6] Laboratoire d'Hématologie, Hôpital Saint Eloi, Montpellier Cedex 5
关键词
D O I
10.1080/03630260601057088
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
ss-Thalassemia (thal), the most common genetic disorder in Egypt, is a major health problem with an estimated, carrier rate of 9-10%. This study, aimed at describing the ss-globin gene mutations in the Suez Canal area, an important Egyptian region, to provide a foundation for a disease control program. We studied 44 ss-thalassemic patients (and their relatives) from 35 families living in this region. The commonest mutations were genetically diagnosed using naturally or amplified created restriction sites. Less frequent mutations were characterized by denaturing gradient get electrophoresis (DGGE) and direct sequencing. Twelve different mutations were identified, in 51 unrelated chromosomes. The three most frequent mutations were IVS-I-110 (G -> A), IVS-I-1 (G -> A) and IVS-I-6 (T -> C). The spectrum of rarer mutations was heterogeneous and d fferedfrom that reported in other areas ofEopl. We also identified thefirst homozygous case of a rare mutation, codon 24 (-G; +CAC), displaying a thalassan'lia major phenotype. Parental consanguinity was high (60.6 %) with 35.7% of the compound heterozygous patients having consanguineous parents. These data provide insightsfor the distribution off ss-thal alletes in this region, and could be used as a basisfor genetic counseling and prenatal, diagnosis.
引用
收藏
页码:49 / 62
页数:14
相关论文
共 17 条
[1]
Ahmed S, 1996, BRIT J HAEMATOL, V94, P476
[2]
ASSESSMENT OF PROSPECTIVE GENETIC-COUNSELING IN THE FERRARA AREA [J].
BARRAI, I ;
VULLO, C .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1980, 6 (03) :195-204
[3]
Survival and disease complications in thalassemia major [J].
Borgna-Pignatti, C ;
Rugolotto, S ;
De Stefano, P ;
Piga, A ;
Di Gregorio, F ;
Gamberini, MR ;
Sabato, V ;
Melevendi, C ;
Cappellini, MD ;
Verlato, G .
COOLEYS ANEMIA: SEVENTH SYMPOSIUM, 1998, 850 :227-231
[4]
Impact of thalassemia major on patients and their families [J].
Caro, JJ ;
Ward, A ;
Greene, TC ;
Huybrechts, K ;
Arana, A ;
Wait, S ;
Eleftheriou, A .
ACTA HAEMATOLOGICA, 2002, 107 (03) :150-157
[5]
El-Beshlawy A, 1999, P ANN M AM PED SOC S
[6]
Identification of novel Asian Indian and Japanese mutations causing beta-thalassaemia in the Egyptian population [J].
ElHashemite, N ;
Petrou, M ;
Khalifa, AS ;
Heshmat, NM ;
Rady, MS ;
Delhanty, JDA .
HUMAN GENETICS, 1997, 99 (02) :271-274
[7]
Ghanem Nada, 1992, Human Mutation, V1, P229, DOI 10.1002/humu.1380010310
[8]
MODIFICATION OF ENZYMATICALLY AMPLIFIED DNA FOR THE DETECTION OF POINT MUTATIONS [J].
HALIASSOS, A ;
CHOMEL, JC ;
TESSON, L ;
BAUDIS, M ;
KRUH, J ;
KAPLAN, JC ;
KITZIS, A .
NUCLEIC ACIDS RESEARCH, 1989, 17 (09) :3606-3606
[9]
MOLECULAR CHARACTERIZATION OF BETA-THALASSEMIA IN EGYPTIANS [J].
HUSSEIN, IR ;
TEMTAMY, SA ;
ELBESHLAWY, A ;
FEARON, C ;
SHALABY, Z ;
VASSILOPOULOS, G ;
KAZAZIAN, HH .
HUMAN MUTATION, 1993, 2 (01) :48-52
[10]
HUSSEIN IR, 1997, EGYPT J GENET CYTOL, V26, P261